Autifony and collaborators publish the results from a clinical trial of AUT00206 in patients with schizophrenia

Autifony and collaborators publish the results from a clinical trial of AUT00206 in patients with schizophrenia

Kaar SJ, Angelescu I, Nour MM, Marques TR, Sharman A, Sajjala A, Hutchison J, McGuire P, Large C, Howes OD. The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophrenia. Psychopharmacology (Berl). 2022 Oct;239(10):3313-3323. doi: 10.1007/s00213-022-06216-3. Epub 2022 Sep 12. PMID: 36094619; PMCID: PMC9481488.

Download Presentation (2.4 MB)